Keyword: cytotoxic facility

Helsinn Reaps Benefits of Cytotoxic Molecule Demand

16.01.2014 - Strong Start - After beginning its investment in a brand-new cytotoxic molecule facility in Biasca, Switzerland, in 2011, Helsinn started production in July 2012. Now one and a...

Pharma- & Biotech Processing

Powder Systems: new contained filtration and drying technology for GMP area

Powder Systems Ltd. - Powder Systems (PSL) supports Helsinn Advanced Synthesis' expansion into the cytotoxic market with their new contained filtration and drying technology. Helsinn Advanced Synthesis...